Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. (OTLK) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001649989 · OTLK · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001649989 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Outlook Therapeutics, Inc. (NASDAQ: OTLK) has submitted 802 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001649989, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Outlook Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Outlook Therapeutics, Inc. 10-K was filed on 2025-12-19 for fiscal year ending 2025. Historical OTLK 10-K annual reports are available from 2015 through 2025.
Investors researching Outlook Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
OTLK SEC Filings · 8 questionsOutlook Therapeutics, Inc. (OTLK) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 802 filings and access original documents at no cost. Outlook Therapeutics, Inc.'s CIK is 0001649989.